Autoimmune hemolytic anemia epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Shyam Patel (talk | contribs) No edit summary |
|||
| (5 intermediate revisions by 5 users not shown) | |||
| Line 2: | Line 2: | ||
{{Autoimmune hemolytic anemia}} | {{Autoimmune hemolytic anemia}} | ||
{{CMG}} '''Assosciate Editor(s)-In-Chief:''' [[User: Prashanthsaddala|Prashanth Saddala M.B.B.S]]; {{shyam}} | {{CMG}} '''Assosciate Editor(s)-In-Chief:''' [[User: Prashanthsaddala|Prashanth Saddala M.B.B.S]]; {{shyam}}, [[User:Irfan Dotani|Irfan Dotani]] [3] | ||
==Overview== | ==Overview== | ||
Overall, the incidence and prevalence of autoimmune hemolytic anemia | Overall, the [[incidence]] and [[prevalence]] of autoimmune hemolytic anemia are low. This condition affects a very small proportion of the population. Autoimmune hemolytic anemia affects men and women equally. There is no racial predilection for autoimmune hemolytic anemia. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
*The incidence of autoimmune hemolytic anemia overall is estimated to be between 0.8 | |||
*The incidence of | === Incidence === | ||
*The incidence of autoimmune hemolytic anemia overall is estimated to be between 0.8 in 100,000 and 3 in 100,000 per year.<ref>{{cite journal |author=Böttiger LE, Westerholm B |title=Acquired haemolytic anaemia. I. Incidence and aetiology |journal=Acta Med Scand |volume=193 |issue=3 |pages=223–6 |year=1973 |month=March |pmid=4739592 }}</ref><ref name="pmid26696798">{{cite journal| author=Berentsen S| title=Role of Complement in Autoimmune Hemolytic Anemia. | journal=Transfus Med Hemother | year= 2015 | volume= 42 | issue= 5 | pages= 303-10 | pmid=26696798 | doi=10.1159/000438964 | pmc=4678321 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26696798 }} </ref><ref name="pmid25271314">{{cite journal| author=Zanella A, Barcellini W| title=Treatment of autoimmune hemolytic anemias. | journal=Haematologica | year= 2014 | volume= 99 | issue= 10 | pages= 1547-54 | pmid=25271314 | doi=10.3324/haematol.2014.114561 | pmc=4181250 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25271314 }} </ref> | |||
*The incidence of drug-induced hemolytic anemia is 1 | *The incidence of [[warm autoimmune hemolytic anemia]] is estimated to be between 1.25 in 100,000 and 1.33 in 100,000.<ref name="pmid26696800">{{cite journal| author=Packman CH| title=The Clinical Pictures of Autoimmune Hemolytic Anemia. | journal=Transfus Med Hemother | year= 2015 | volume= 42 | issue= 5 | pages= 317-24 | pmid=26696800 | doi=10.1159/000440656 | pmc=4678314 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26696800 }} </ref> | ||
*The prevalence of autoimmune hemolytic anemia is 17 | *The incidence of [[Drug induced hemolytic anemia (patient information)|drug-induced hemolytic anemia]] is 1 in 1,000,000.<ref name="pmid26696800">{{cite journal| author=Packman CH| title=The Clinical Pictures of Autoimmune Hemolytic Anemia. | journal=Transfus Med Hemother | year= 2015 | volume= 42 | issue= 5 | pages= 317-24 | pmid=26696800 | doi=10.1159/000440656 | pmc=4678314 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26696800 }} </ref> | ||
=== Prevalence === | |||
*The prevalence of autoimmune hemolytic anemia is 17 in 100,000.<ref name="pmid25271314">{{cite journal| author=Zanella A, Barcellini W| title=Treatment of autoimmune hemolytic anemias. | journal=Haematologica | year= 2014 | volume= 99 | issue= 10 | pages= 1547-54 | pmid=25271314 | doi=10.3324/haematol.2014.114561 | pmc=4181250 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25271314 }} </ref> | |||
=== Age === | |||
* The incidence of autoimmune hemolytic anemia in children is 0.2 in 100,000.<ref name="pmid25271314" /> | |||
* The incidence of autoimmune hemolytic anemia is higher in adults that in children.<ref name="pmid26696798" /> | |||
=== Race === | |||
* Autoimmune hemolytic anemia affects all racial backgrounds equally. | |||
=== Gender === | |||
*Autoimmune hemolytic anemia affects men and women equally. | *Autoimmune hemolytic anemia affects men and women equally. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Latest revision as of 11:56, 20 September 2018
|
Autoimmune hemolytic anemia Microchapters |
|
Differentiating Autoimmune hemolytic anemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Autoimmune hemolytic anemia epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Autoimmune hemolytic anemia epidemiology and demographics |
|
FDA on Autoimmune hemolytic anemia epidemiology and demographics |
|
CDC on Autoimmune hemolytic anemia epidemiology and demographics |
|
Autoimmune hemolytic anemia epidemiology and demographics in the news |
|
Blogs on Autoimmune hemolytic anemia epidemiology and demographics |
|
Directions to Hospitals Treating Autoimmune hemolytic anemia |
|
Risk calculators and risk factors for Autoimmune hemolytic anemia epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Assosciate Editor(s)-In-Chief: Prashanth Saddala M.B.B.S; Shyam Patel [2], Irfan Dotani [3]
Overview
Overall, the incidence and prevalence of autoimmune hemolytic anemia are low. This condition affects a very small proportion of the population. Autoimmune hemolytic anemia affects men and women equally. There is no racial predilection for autoimmune hemolytic anemia.
Epidemiology and Demographics
Incidence
- The incidence of autoimmune hemolytic anemia overall is estimated to be between 0.8 in 100,000 and 3 in 100,000 per year.[1][2][3]
- The incidence of warm autoimmune hemolytic anemia is estimated to be between 1.25 in 100,000 and 1.33 in 100,000.[4]
- The incidence of drug-induced hemolytic anemia is 1 in 1,000,000.[4]
Prevalence
- The prevalence of autoimmune hemolytic anemia is 17 in 100,000.[3]
Age
- The incidence of autoimmune hemolytic anemia in children is 0.2 in 100,000.[3]
- The incidence of autoimmune hemolytic anemia is higher in adults that in children.[2]
Race
- Autoimmune hemolytic anemia affects all racial backgrounds equally.
Gender
- Autoimmune hemolytic anemia affects men and women equally.
References
- ↑ Böttiger LE, Westerholm B (1973). "Acquired haemolytic anaemia. I. Incidence and aetiology". Acta Med Scand. 193 (3): 223–6. PMID 4739592. Unknown parameter
|month=ignored (help) - ↑ 2.0 2.1 Berentsen S (2015). "Role of Complement in Autoimmune Hemolytic Anemia". Transfus Med Hemother. 42 (5): 303–10. doi:10.1159/000438964. PMC 4678321. PMID 26696798.
- ↑ 3.0 3.1 3.2 Zanella A, Barcellini W (2014). "Treatment of autoimmune hemolytic anemias". Haematologica. 99 (10): 1547–54. doi:10.3324/haematol.2014.114561. PMC 4181250. PMID 25271314.
- ↑ 4.0 4.1 Packman CH (2015). "The Clinical Pictures of Autoimmune Hemolytic Anemia". Transfus Med Hemother. 42 (5): 317–24. doi:10.1159/000440656. PMC 4678314. PMID 26696800.